---
title: "BMO 將禮來目標價從 850 美元上調至 930 美元。"
description: "BMO 將禮來目標價從 850 美元上調至 930 美元。"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/261862614.md"
published_at: "2025-10-20T10:58:21.000Z"
---

# BMO 將禮來目標價從 850 美元上調至 930 美元。

BMO 將禮來目標價從 850 美元上調至 930 美元。

### Related Stocks

- [LLY.US - 禮來](https://longbridge.com/zh-HK/quote/LLY.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| BMO Balanced ETF (Fixed Distr Units) declares CAD 0.049 dividend | BMO Balanced ETF (Fixed Distr Units) declares CAD 0.049 dividend | [Link](https://longbridge.com/zh-HK/news/276366133.md) |
| BMO Says Canada's Housing Construction Will Take Time To Pick Up | BMO Says Canada's Housing Construction Will Take Time To Pick Up | [Link](https://longbridge.com/zh-HK/news/276230710.md) |
| Couche-Tard Brief: BMO Says Co "Provided For a Slight Acceleration To Organic Growth From Recent Trend" | Couche-Tard Brief: BMO Says Co "Provided For a Slight Acceleration To Organic Growth From Recent Trend" | [Link](https://longbridge.com/zh-HK/news/275778205.md) |
| Eli Lilly (LLY) Builds $1.5 Billion Inventory of Weight-Loss Pill | Eli Lilly (LLY) has prepared a $1.5 billion inventory of its new weight-loss pill, Orforglipron, ahead of its anticipate | [Link](https://longbridge.com/zh-HK/news/276070062.md) |
| Couche-Tard Brief: Keeps Marketperform Rating, Target Raised To $84 at BMO On Takeaways From Co's 2026 Business Strategy Update | Couche-Tard Brief: Keeps Marketperform Rating, Target Raised To $84 at BMO On Takeaways From Co's 2026 Business Strategy | [Link](https://longbridge.com/zh-HK/news/275778147.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。